Max Robotics — Global Service Robot Directory + US Certification

About

Koichi Hyakutake is a leading figure in neurorehabilitation robotics, with a focused expertise in developing and validating the Hybrid Assistive Limb (HAL) for post-stroke recovery. His research centers on the "interactive biofeedback" theory, demonstrating how HAL’s exoskeleton technology can retrain neural pathways and restore motor function. Hyakutake’s major contributions include pioneering tailor-made rehabilitation protocols that integrate multiple HAL robots for acute stroke patients, as well as combining HAL therapy with botulinum toxin A injections to manage spastic hemiplegia. His work has shown that robotic therapy is effective not only in clinical settings but also in home-based environments for chronic stroke survivors, significantly expanding access to care. With his most-cited paper (59 citations) providing a proof-of-concept using functional near-infrared spectroscopy, Hyakutake has established a robust evidence base for robot-assisted rehabilitation. His systematic reviews and case series further clarify patient selection criteria, ensuring that HAL therapy is optimally deployed based on stroke severity. Through these innovations, Hyakutake is shaping the future of personalized, technology-driven stroke rehabilitation.